Cannara Biotech Inc (LOVE) — Cash Flow Reinvestment Rate
Cannara Biotech Inc (LOVE) has a Cash Flow Reinvestment Rate of 0.58x as of November 2025, reinvesting CA$4.62 Million (capex CA$4.62 Million ) from operating cash flow of CA$7.96 Million. See Cannara Biotech Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cannara Biotech Inc Cash Flow Reinvestment Rate (2023–2025)
Historical reinvestment intensity for Cannara Biotech Inc across 3 annual periods. For the full cash flow conversion analysis, see LOVE operating cash flow.
Annual Cash Flow Reinvestment Rate for Cannara Biotech Inc (2023–2025)
Year-by-year capital reinvestment analysis for Cannara Biotech Inc. See Cannara Biotech Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.62x | CA$12.31 Million | CA$20.01 Million | CA$6.36 Million | ▼ -48.1% |
| 2024 | 1.18x | CA$12.66 Million | CA$10.68 Million | CA$7.47 Million | ▼ -63.8% |
| 2023 | 3.27x | CA$19.36 Million | CA$5.91 Million | CA$9.88 Million | — |